gunda georg
medicinal chemistry wordmark
Dr. Gunda Georg receives the Mannich Medal


YourChoice Therapeutics, Inc., a pioneer of hormone-free family planning products, began dosing male volunteers in a phase one clinical study of YCT-529, a drug candidate designed to offer the first hormone-free male birth control pill. The initial preclinical studies, funded in part by the…

The laboratories of Dr. Gunda Georg and Dr. Daniel Harki collaborated on a recent publication in Nature Communications regarding the discovery of a new allosteric inhibitors that bind to CDK2.

Cyclin-dependent kinase 2 (CDK2), part of the enzyme family responsible for controlling…